Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.50
+0.37 (7.21%)
At close: Jun 26, 2026, 4:00 PM EDT
5.55
+0.05 (0.91%)
After-hours: Jun 26, 2026, 7:19 PM EDT
Coya Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Coya Therapeutics stock have an average target of 15.4, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 180.00% from the current stock price of 5.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Coya Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 5 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +227.27% | Jun 25, 2026 |
| Roth MKM | Roth MKM | Buy Initiates $12 | Buy | Initiates | $12 | +118.18% | Jun 5, 2026 |
| Lake Street | Lake Street | Buy Maintains $17 | Buy | Maintains | $17 | +209.09% | May 22, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $14 | Buy | Maintains | $14 | +154.55% | May 13, 2026 |
| BTIG | BTIG | Buy Maintains $16 | Buy | Maintains | $16 | +190.91% | Mar 17, 2026 |
Financial Forecast
Revenue This Year
2.35M
from 7.95M
Decreased by -70.45%
Revenue Next Year
4.96M
from 2.35M
Increased by 111.34%
EPS This Year
-1.48
from -1.27
EPS Next Year
-1.83
from -1.48
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.3M | 14.7M | |
| Avg | 2.3M | 5.0M | |
| Low | 251,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 29.0% | 524.9% | |
| Avg | -70.5% | 111.3% | |
| Low | -96.8% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.42 | -1.66 | |
| Avg | -1.48 | -1.83 | |
| Low | -1.52 | -2.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.